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Nucleus pulposus (NP) tissue damage can induce detrimental mechanical strain on the biomechanical perfor-
mance of intervertebral discs (IVDs), causing subsequent disc degeneration. A novel, photocurable, injectable, 
synthetic polymer hydrogel (pHEMA-co-APMA grafted with PAA) has already demonstrated success in encap-
sulating and differentiating human mesenchymal stem cells (hMSCs) toward an NP phenotype during hypoxic 
conditions. After demonstration of promising results in our previous work, in this study we have further inves-
tigated the inclusion of mechanical stimulation and its impact on hMSC differentiation toward an NP pheno-
type through the characterization of matrix markers such as SOX-9, aggrecan, and collagen II. Furthermore, 
investigations were undertaken in order to approximate delivery parameters for an injection delivery device, 
which could be used to transport hMSCs suspended in hydrogel into the IVD. hMSC-laden hydrogel solutions 
were injected through various needle gauge sizes in order to determine its impact on postinjection cell viability 
and IVD tissue penetration. Interpretation of these data informed the design of a potential minimally invasive 
injection device, which could successfully inject hMSCs encapsulated in a UV-curable polymer into NP, prior 
to photo-cross-linking in situ.
Key words: Regenerative medicine; Cell encapsulation; Tissue engineering;  
Cell delivery; Device design
INTRODUCTION
Biomechanical and pathohistological structure changes 
occur in the degenerated intervertebral disc (IVD). The dif-
ficulty in IVD tissue to repair and regenerate itself is attrib-
uted to its relatively acellular (5,000 cells/mm3), acidic, 
and avascular environment. Subsequently, when consid-
ering an acellular or tissue engineering therapy for IVD, 
several factors must be considered, including extracellular 
matrix architecture, hydrated tissue matrix, hypoxic nature, 
and the mechanical stresses and strains imposed upon the 
nucleus pulposus (NP) tissue. For this reason, hydrogels 
are an ideal and popular choice, as they are able to offer a 
hydrated environment, they have the ability to mimic native 
fibrillar structure, and are biocompatible1,2. Furthermore, 
photocurable hydrogels display additional benefits, includ-
ing fine-tuning mechanical properties and swelling behav-
ior, short reaction times, minimal heating, and minimally 
invasive delivery. To date, only a single study exists that 
has displayed the successful use of a photocurable poly-
ethyelene glycol diacrylate hydrogel to encapsulate and 
differentiate mesenchymal stem cells (MSCs) toward 
NP-like cells, proven by the positive expression of typical 
NP matrix proteins (aggrecan and collagen II)3.
Various parameters have been demonstrated to influ-
ence the differentiation of human MSCs (hMSCs) toward 
an NP cell-like phenotype including a 3D environment sup-
ported by hydrogels4, hypoxia and chemical stimulation, 
and disc microenvironment5. A study by Stoyanov et al. 
This article is licensed under a Creative Commons Attribution 4.0 International License.
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Figure 1. Gene expression. Real-time polymerase chain reaction (RT-PCR) demonstrating the expression of typical intervertebral disc 
(IVD) markers: (A) SOX-9, (B) aggrecan, (C) collagen II in primary chondrocytes (OK cells), and human mesenchymal stem cells 
(hMSCs) cultured in 2D and 3D (hydrogels) environments, in hMSC or chondrogenic media, under static or stimulated conditions in 
hypoxia up to 14 days. Annotations: human chondrocytes (OK), MSCs cultured in MSC expansion media (MSC MM), MSCs cultured 
in chondrogenic media (MSC CM), on tissue culture plastic (2D) and within hydrogels (3D), glyceraldehyde-3-phosphate dehydroge-
nase glyceraldehyde 3-phosphate dehydrogenase (GAPDH). ***p < 0.001, statistically significant.
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demonstrated the successful differentiation of hMSCs 
toward NP cells under the combined influence of 3D 
encapsulation using alginate beads and chemical media6. 
Recently, our group demonstrated the successful use of a 
novel, synthetic, ultraviolet (UV) photocurable hydrogel 
polyhydroxyl ethyl methacrylate-co-N-3-aminopropylme 
thacrylamide grafted with polyamidoamine [p(HEMA-
co-APMA)g PAA] for the encapsulation of hMSCs and 
their differentiation toward an NP-cell like phenotype7. In 
this case, differentiation was achieved through the mul-
tiple combinatorial effects of 3D encapsulation, chondro-
genic media, and hypoxia. In this study, we have further 
investigated the additional influence of mechanical stim-
ulation to hMSC differentiation and also demonstrated 
the feasibility of cell delivery using injection devices.
MATERIALS AND METHODS
Preparation of Photocurable Hydrogel Solution
pHEMA-APMA-PAA polymer (Fondazione Filarete, 
Milan, Italy) was prepared as described previously7. 
Briefly, hydrogels were prepared at 13.5% (w/v) concen-
tration by dissolving the required amount of polymer in 
phosphate-buffered saline (PBS; Sigma-Aldrich, Dorset, 
UK). Irgacure 2959 [2-hydroxy-4¢-(2-hydroxyethoxy)-2-
methylpropiophenone; 50% (w/v)] was prepared using 
dimethyl sulfoxide (DMSO; Sigma-Aldrich) solution, 
which was added to the polymer solution at 1% volume of 
the total polymer solution. Polymer solution was briefly 
vortexed and sterile filtered before use.
hMSC Expansion, Encapsulation in Hydrogels, 
and Differentiation Toward NP-Like Cells
hMSCs from fresh human bone marrow aspirate sup-
plied by Lonza (Catalog No. 1M-125; IRB approved; 
Walkersville, MD, USA) were recovered, isolated, and 
expanded as described previously by Pittenger et al.8. 
hMSCs were expanded using hMSC expansion media, 
which consisted of Dulbecco’s modified Eagle’s medium 
(DMEM), 10% fetal bovine serum (FBS; Lonza), 1% 
L-glutamine (L-glut; Lonza), 1% nonessential amino acids 
(NEAA; Lonza), and 1% penicillin and streptomycin and 
incubated in a hypoxic chamber at 2% O2 SCI-Tive work-
station (RUSKINN Technology; The Baker Company, 
Bridgend, UK). Seeding solutions consisted of 200,000 
cells/50 µl of hMSC media per hydrogel. Cell seeding 
solution and cross-linking were performed as mentioned 
in our previous work7. Chondrogenic medium [consist-
ing of DMEM, 1% FBS, 1% NEAA, 1% L-glut, 0.1 µM 
dexamethasone, 50 µM ascorbic acid, 40 µg/ml L-proline, 
1% sodium pyruvate, and 10 ng/ml transforming growth 
factor-b3 (TGF-b3)] was conditioned in hypoxia at 2% 
O2 using the SCI-Tive workstation for 24 h prior to 
use. Mechanical stimulation to biological samples was 
applied using the BOSE bioreactor (Minneapolis, MN, 
USA). Stimulation parameters of cyclic compression 
(5%) at 1 Hz for 15 min a day, up to day 7 or 14, were 
applied. hMSCs encapsulated in hydrogels were cultured 
in hMSC media under normoxic conditions or in chon-
drogenic media under hypoxic conditions and then were 
loaded into the biodynamic chamber using sterile forceps. 
Mechanical stimulation was performed for 15 min, after 
which point samples were placed back into culture within 
the SCI-Tive workstation until the following day.
PCR Analysis of Chondrogenic Markers  
(Static vs. Mechanical Stimulation)
One-step quantitative real-time polymerase chain reac-
tion (qRT-PCR) was performed using the SuperScript 
III Platinum SYBR Green enzyme (Part No. 11736051; 
Invitrogen, Paisley, UK) according to manufacturer’s in- 
structions. Primers (F indicates forward primer, R indi-
cates reverse primer, and annealing temperature used 
is indicated for each primer pair) were purchased from 
Qiagen (Manchester, UK) [aggrecan (ACAN), Part No. 
QT00001365; collagen II, SLCO2A1, Part No. QT0009 
5375; SOX-9, Part No. QT00001498; and glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), Part No. QT011 
92646]. All qRT-PCRs comprised a single cycle of 50°C 
for 3 min, a single cycle of 95°C for 5 min, followed by 
40 cycles of 95°C for 15 s, annealing temperature of 45°C 
for 30 s and 72°C for 1 min, finally followed by a single 
cycle of 40°C for 1 min using the thermocycler machine. 
Raw cycle threshold (Ct) values of interested genes were 
normalized to raw Ct values of the housekeeping gene 
GAPDH to attain DCt
 
values per gene. These values were 
then converted to DDCt
 
values, which were the final values 
used in Figure 1.
Evaluation of Cell Viability After Injection 
Through Different Needle Gauges
Trypsinized hMSCs were resuspended homogenously 
into the polymer hydrogel solution (prephotocuring) at 
a cell density of 100,000 cells/50 µl polymer solution. 
hMSC/polymer solutions were injected using different 
surgical gauge size needles (19, 22, 27, and 30 gauge; 
Terumo; Fisher Scientific, Loughborough, UK) into a 
six-well plate and incubated at 2% O2 for 1 and 24 h. Cell 
viability was evaluated using trypan blue and live/dead 
staining solutions (Sigma-Aldrich), as used previously in 
our study7.
IVD Penetration Force Study
Frozen oxtail IVDs obtained from a local butcher 
shop were thawed to room temperature prior to use. 
Various size needles (22, 25, 27, and 30 gauge) were 
fixed to a compressive testing machine (Model 5848; 
Instron Ltd., High Wycombe, UK). This was achieved 
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using a stainless steel adaptor (Fig. 4A) that could 
receive a 2-ml syringe barrel with reduced length and 
a tip for needle attachment (Terumo; Fisher Scientific). 
The bespoke adaptor attached to the mobile upper jaw 
of the testing machine.
The machine was set in compression mode with a 5-N 
load cell installed, and the mobile upper jaw of the tester 
was programmed to travel at a rate of 1 mm/s. The oxtail 
was affixed to a polystyrene sheet using spare needles 
to prevent the sample from moving during penetration 
(Fig. 4B). For each experiment, the needle was pushed 
into the IVD by approximately 5 mm. This penetration 
depth ensured the needle would push past the annulus 
fibrosis (AF) and enter into the NP.
RESULTS AND DISCUSSION
Effects of 3D Culture and Cyclic Compression
In this study, further insights were examined in terms 
of specifying the power and impact of each of the stimu-
lating parameters (hydrogel, hypoxia, chemical environ-
ment, and mechanical stimulation) individually on the 
differentiation process of hMSCs toward an NP cell-like 
phenotype. PCR analysis revealed that the 3D culture of 
hMSCs within the hydrogel under hypoxic conditions 
triggered the differentiation of hMSCs toward an NP cell-
like phenotype (Fig. 1). This was shown through elevated 
gene expression of SOX-9 (Fig. 1A), aggrecan (Fig. 1B), 
and collagen II (Fig. 1C) at day 14 when compared to 
the 2D culture in hMSC media. When combining cell–gel 
constructs under hypoxia and in chondrogenic media, the 
gene expression of SOX-9 (Fig. 1A), aggrecan (Fig. 1B), 
and collagen II (Fig. 1C) was further elevated at day 14. 
However, the significant decrease in gene expression 
from day 7 to day 14 in hypoxia and chondrogenic media 
may have been attributed to the complete transcriptional 
switch from a stem cell to a terminally differentiated NP 
cell-like phenotype and that translational expression of 
matrix proteins could take place after day 7 during in 
vitro culture.
We next integrated mechanical stimulation to the 
study and investigated the effects of 5% cyclic compres-
sion, 1 Hz, 15 min a day, and up to day 14, on hMSCs 
encapsulated within hydrogels, under hypoxia, in hMSC 
or chondrogenic media. Immunocytochemistry was used 
to reveal the translational expression of key NP matrix 
proteins aggrecan and collagen II. Minimal differences 
in the expression of aggrecan and collagen II were wit-
nessed when culturing hMSCs [2D, on tissue culture 
plastic (TCP); or 3D, cells encapsulated within hydrogels] 
in hMSC media under hypoxia (Fig. 2A and C). However, 
it was apparent that after the addition of chondrogenic 
media, further elevated levels of aggrecan and collagen II 
were witnessed when cultured under hypoxic conditions 
for 14 days (Fig. 2B and D). Interestingly, the greatest 
level of translational expression of both aggrecan and col-
lagen II was witnessed in hydrogels cultured in hypoxia 
and chondrogenic media and exposed to mechanical 
stimulation up to day 14 (Fig. 2). This in vitro 3D culture 
with mechanical stimulation demonstrated the ability to 
support hMSC viability and differentiation toward an NP 
cell-like phenotype. However, further improvements to 
the model can be made in order to mimic the mechani-
cal stimulation parameters close to the biomechanics of 
IVD by applying a more long-term mechanical stimula-
tion regime.
Postinjection Viability of Cells
Coupled together with the ability of the hydrogels to 
provide protection to the encapsulated cells and mechani-
cal support to the surrounding tissue in vivo, the ability to 
deliver cells in a minimally invasive procedure to the tar-
get site as well as the ability of the hydrogel to photocure 
in situ after delivery prompted the consideration in the 
delivery parameters for a device that would be used for 
local delivery of cell-laden hydrogel solution in vivo. To 
minimize the damage to the IVD from the needle penetra-
tion, needles with smaller diameter are ideal. However, 
narrower needle gauges could cause damage to the cells 
because of shear stresses imposed within the needle bore. 
Hence the logical step in determining the most suitable 
needle gauge (Fig. 3A) to deliver hMSC-laden hydrogels 
was to establish the effect of the inner diameter of the 
needle used on cell viability after delivery.
Heng et al.9 have reported that passing hMSCs through 
a narrower catheter (26-gauge nitinol needle lumen) at 
flow rates, which are normally encountered, resulted in 
no changes in hMSC multipotency or viability. This was 
an intramyocardial injection of hMSCs directly into the 
heart muscle. In another study by Garvican et al.10, no 
changes in stem cell differentiation were observed when 
injected through 19-, 21-, or 23-gauge needles. However, 
there was a compromise in viability injecting through 21- 
and 23-gauge needles. The general consensus therefore 
appears to be the preference by clinicians for smaller-
bore needles for hMSC delivery11.
As the proposed route of delivery is to 1) inject cell 
hydrogel solution in situ followed by 2) cross-linking 
using a UV source, it was imperative to investigate various 
needle gauges (22, 25, 27, and 30 gauge) and the impact 
on cell viability. Observations revealed that after injection 
hMSCs retained good cell viability on TCP with the abil-
ity to fully recover their typical fibroblastic morphology in 
24 h (Fig. 3B). Insignificant differences in viability were 
observed between 22, 25, and 27 gauge, although signifi-
cant differences in cell viability were witnessed with 30 
gauge compared to all other sizes (Fig. 3B and C). These 
data are in agreement with literature suggesting the use of 
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22- to 27-gauge needles. The minimal cell death may be 
attributed to the masking/protection of cells through the 
viscosity of the polymer from the impact of shear forces 
applied by these needles12,13. However, a limitation of this 
experiment includes the inability to precisely control the 
flow rates, which could contribute to the large standard 
deviation on the average number of dead cells observed 
in Figure 3C. Future studies could include delivery using 
various flow rates controlled by an electrical motor, but 
we feel manual injection would reflect the manner of 
stem cell delivery more closely to the medical procedures 
deployed in a clinical setting14,15.
After delivery, photo-cross-linking of cell-loaded hydro-
gel solution would take place in situ, where our previous 
study and others have confirmed insignificant compro-
mise on viability using the photoinitiator and the UV 
parameters7. In addition, no secondary surgical interven-
tion would be required after therapy, as the hydrogel is 
designed/tailored to break down with degradation prod-
ucts less than 20 kDa (limit for renal filtration), allowing 
efficient smooth excretion of the polymer by-products 
through the metabolic pathway, preventing subsequent 
localized accumulation of hydrogel by-products16.
Quantification of Tissue Penetration Force
Needle penetration forces into IVD were investigated 
using an ex vivo tissue model. Explant IVD tissue from 
oxtail (with similar dimensions and mechanical proper-
ties to human IVD) was penetrated using different needle 
gauges (Fig. 4A–C). Greater variation in penetration 
force was observed using larger needle gauge and is prob-
ably attributed to the larger outer diameter of the needle, 
resulting in greater and controlled tearing of the tissue 
as it penetrates through the AF (Fig. 4D). The 22-gauge 
needle was shown to require the greatest mean force to 
penetrate 2.17 N (1.39% SD), the 30-gauge needle was 
shown to have the lowest force to penetrate with the pen-
etration point being the most consistent with a mean of 
0.51 N (0.04% SD) (Fig. 4D). Smaller penetration forces 
were encountered using smaller needles, but it is also 
important to ensure that cell viability is not compromised 
through direct shear forces, although this does not appear 
to be the case here. Hence the selection of delivery device 
parameters would be a negotiation between the inter-
nal diameter to ensure cell viability and the request of 
a small needle gauge to ensure negligible effect on IVD 
integrity17,18. It is anticipated that a suitable minimally 
Figure 2. Intervertebral disc (IVD) matrix protein expression. Immunocytochemistry demonstrating the expression of typical IVD 
matrix proteins; collagen II expression in human mesenchymal stem cells (hMSCs) cultured on tissue culture-treated plastic (TCP) 
or within hydrogels under static and stimulated conditions at day 7 and day 14 of culture in (A) hMSC differentiation media and (B) 
chondrogenic media. Aggrecan expression in hMSCs cultured within hydrogels under static and stimulated conditions at day 7 and day 
14 of culture in (C) hMSC differentiation medium and (D) chondrogenic medium.
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invasive delivery device must be able to exert approxi-
mately a force of 2.5 N, which is required to successfully 
penetrate through the AF of an IVD. The needle gauge of 
the device could be in the range of 19–30 gauge, although 
using a smaller-bore needle can minimize penetration 
forces, but also it will increase the pressure required on 
the back of a syringe, most likely when a viscous hydro-
gel solution is delivered.
Delivery Device Design
Having taken all parameters and outcomes into con-
sideration, the formulated computer-aided design (CAD) 
model of the chosen delivery design is displayed in 
Figure 4E. Major design components include a consum-
able cell reservoir of hMSCs and hydrogel solution, 
battery-powered stepper motor with controlled injection, 
and corresponding control and feedback components. 
This allows accurate and precise volumetric delivery via 
an electromechanical device facilitating intelligent con-
trol of the delivery force. The possibility of a battery-
powered device improves its ergonomic performance, 
as no wires would hinder the final positional control by 
the surgeon. Briefly, injection of hMSC-loaded hydrogel 
solution is controlled through a rocker trigger activated 
with the user’s forefinger. How ever, further investiga-
tions would be required to perform proof-of-concept 
studies using the device with an in vivo preclinical model 
(bovine or ovine).
Preliminary assessment of the injectable parameters 
has provided insights into the design of an injection device 
capable of delivering a UV-curable hydrogel loaded with 
hMSCs that could be used to inject through the AF and 
into the NP. It is anticipated that the delivery method 
would be minimally invasive. This is attributed to the 
fact that the device would have a narrow enough needle 
to penetrate through the AF and into the NP. The cannula 
would then be changed to allow injection/delivery of the 
hMSC-loaded polymer solution with the photoinitiator 
to the delivery site. Following delivery, a probe would 
then follow through the catheter to the target site allow-
ing the exposure of UV light with optimized parameters 
to permit photocuring in situ. Once cured, the properties 
of the hydrogel would help to restore mechanical func-
tion of IVD for the time being2,19 until the developmental 
Figure 3. Injection delivery route evaluation using different needle gauge sizes. (A) The table defines the dimensions of the different 
size gauge needles in millimeters (mm) used to inject human mesenchymal stem cells (hMSCs) into a well plate. (B) hMSC viability 
(live/dead staining) 24 h after injection through various size needle gauges (scale bars: 100 µm). (C) Quantification of the percentage 
of hMSC dead cells (trypan blue) 1 h after injection through various size needle gauges. *p < 0.05, **p < 0.01.
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state of hMSCs and cell/scaffold interactions are proper 
for effective extracellular matrix production, hence con-
tributing to the repair of the NP tissue5,20,21.
CONCLUSIONS
This study has demonstrated the successful use of a 
UV photocurable, synthetic hydrogel in encapsulating 
hMSCs and differentiating them toward an NP cell-like 
phenotype when cultured in a combined environment of 
hypoxia, chemical stimulation, and mechanical stimula-
tion. In addition, we have considered the delivery route 
of the cell-loaded hydrogel solution in situ, have demon-
strated adequate cell viability and morphology after injec-
tion using 22- and 27-gauge needles, and quantified the 
force required for successful penetration through the AF.
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